Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Patient Positioning × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Disease 1 Breast Neoplasms 1

Interventions

Mammography 4 Magnetic Resonance Spectroscopy 3 pembrolizumab 1 Therapeutics 1 TKM-080301 1 Surveys and Questionnaires 1 Sensitivity Training Groups 1 Referral and Consultation 1 Quality of Life 1 Patient Positioning 1 Paclitaxel 1 Methylene Blue 1 Mass Screening 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Interleukin-15 1 Gemcitabine 1 Drug Delivery Systems 1 Doxorubicin 1 Counseling 1 Blood Specimen Collection 1 Biopsy 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02865239 2018-08-08

EFIMED

Institut de Cancérologie de Lorraine

Phase NA Completed

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡